The Scenic City Difference

MSKIT® — Minimally Stimulated Ketamine Infusion Therapy — consistently demonstrates the highest patient-reported relief of depressive symptoms across all ketamine administration modalities. Here’s why.

The Protocol

Why MSKIT® Outperforms

Chronic stress and trauma reduce the brain’s ability to process information and communicate between neural pathways. MSKIT® increases neural capacity, allowing the brain to form new, healthier connections that support recovery from anxiety, depression, and pain. Patients consistently report 85% or greater remission of symptoms after completing the Stabilization Phase.

• ✓Minimally stimulated environment — calm, private treatment rooms designed to let the brain do its work without sensory overload
• ✓Expert CRNA-led care — every infusion is administered by a Certified Registered Nurse Anesthesiologist with optimal dosing for optimal outcomes
• ✓NAD+ adjuncts included — ketamine creates neuroplasticity while NAD+ supplies the biologic compounds your brain needs to function optimally
• ✓Real-time outcome tracking — the Osmind app collects data throughout treatment so we can adjust care to your needs
• ✓Post-Stabilization Success Plan — a dedicated provider meeting to turn your neuroplastic window into lasting change

The neuroplastic window is strongest in the days after treatment — we make sure it counts.

The Science

Built on Research, Proven in Practice

Ketamine blocks NMDA receptors, triggering a glutamate surge that activates AMPA receptors and stimulates the release of BDNF — leading to increased neuroplasticity. The neuroplastic window is strongest in the days after treatment, which is why our protocols pair each infusion with structured follow-up: the work you do outside the treatment room takes hold more effectively.

As a registered research location, we contribute clinical data to national research initiatives through the Osmind community, and our 2022–2024 research across 252 patients shows an 82% response rate. See more on our Research & Resources page.